SCI Pharmtech Inc (4119) — Cash Flow Quality Index
SCI Pharmtech Inc (4119) has a Cash Flow Quality Index of 1.62x as of December 2025. Operating cash flow of NT$62.91 Million exceeds net income of NT$38.86 Million, indicating high earnings quality where cash backs reported profits. Explore SCI Pharmtech Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SCI Pharmtech Inc Cash Flow Quality Index (2002–2025)
Historical Cash Flow Quality Index for SCI Pharmtech Inc across 23 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of SCI Pharmtech Inc to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for SCI Pharmtech Inc (2002–2025)
Year-by-year earnings quality comparison for SCI Pharmtech Inc. For live market cap and the full company financial profile, see SCI Pharmtech Inc (4119) market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.05x | NT$220.32 Million | NT$107.37 Million | ▲ +54.2% |
| 2024 | 1.33x | NT$860.52 Million | NT$646.86 Million | ▲ +124.5% |
| 2023 | 0.59x | NT$215.77 Million | NT$364.19 Million | ▼ -22.5% |
| 2022 | 0.76x | NT$296.56 Million | NT$387.82 Million | ▼ -82.1% |
| 2021 | 4.28x | NT$280.28 Million | NT$65.51 Million | ▲ +100.5% |
| 2020 | 2.13x | NT$971.53 Million | NT$455.21 Million | ▲ +91.7% |
| 2019 | 1.11x | NT$791.60 Million | NT$711.16 Million | ▲ +26.3% |
| 2018 | 0.88x | NT$480.18 Million | NT$544.79 Million | ▼ -26.5% |
| 2017 | 1.20x | NT$281.65 Million | NT$234.77 Million | ▲ +20.8% |
| 2016 | 0.99x | NT$502.11 Million | NT$505.70 Million | ▼ -32.4% |
| 2015 | 1.47x | NT$663.24 Million | NT$451.49 Million | ▲ +37.2% |
| 2014 | 1.07x | NT$358.77 Million | NT$335.09 Million | ▼ -13.0% |
| 2013 | 1.23x | NT$238.57 Million | NT$193.78 Million | ▼ -37.9% |
| 2012 | 1.98x | NT$385.57 Million | NT$194.45 Million | ▼ -28.5% |
| 2011 | 2.77x | NT$249.55 Million | NT$90.02 Million | ▲ +116.8% |
| 2010 | 1.28x | NT$218.96 Million | NT$171.24 Million | ▼ -32.9% |
| 2009 | 1.91x | NT$316.96 Million | NT$166.31 Million | ▲ +21.7% |
| 2008 | 1.57x | NT$245.29 Million | NT$156.60 Million | ▲ +40.7% |
| 2007 | 1.11x | NT$167.53 Million | NT$150.51 Million | ▼ -61.1% |
| 2006 | 2.86x | NT$131.62 Million | NT$45.98 Million | ▲ +56.1% |
| 2004 | 1.83x | NT$76.61 Million | NT$41.78 Million | ▼ -22.7% |
| 2003 | 2.37x | NT$206.86 Million | NT$87.19 Million | ▲ +84.8% |
| 2002 | 1.28x | NT$107.12 Million | NT$83.44 Million | — |